Opendata, web and dolomites

TRILLIO SIGNED

TRILLIO, a porTable pRescription assistant Improving heaLth of Europeans citizens by increasing therapeutic adherence in eLderly people and in patIents affected by chrOnic diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TRILLIO project word cloud

Explore the words cloud of the TRILLIO project. It provides you a very rough idea of what is the project "TRILLIO" about.

connected    act    causes    market    person    adherence    nokia    tested    alerts    treatments    50    comanda    time    endorsement    000    medication    150    connections    trillio    press    la    poor    care    provider    sure    automatically    recommendations    alarm    turnover    device    site    suitable    hospitals    drug    suffering    plan    app    difficulties    selling    italy    right    corresponds    pilot    treatment    sends    andrea    ten    carlo    executives    deaths    diet    2    small    completing    500    off    aifa    demo    launching    players    visual    notification    mobile    gaggi    clock    minutes    serval    medical    lifestyle    family    familiar    burdens    feasibility    chronic    source    expenditure    optimizes    turn    purpose    therapy    therapeutic    button    paper    2023    received    startup    abroad    italian    former    billion    distributing    team    diseases    executing    pharmaceutical    follows    112    elderly    200    innovative    population    agreed    share    founders    display    generate    patient    sound    showing    17m    brianza    really    health   

Project "TRILLIO" data sheet

The following table provides information about the project.

Coordinator
LA COMANDA SRL 

Organization address
address: VIA BARTOLOMEO EUSTACHI 52
city: MILANO
postcode: 20129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.trillio.org/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LA COMANDA SRL IT (MILANO) coordinator 50˙000.00

Map

 Project objective

'Therapeutic adherence is defined as “the extent to which a person’s behaviour – taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider”. It is estimated that each year the poor adherence to medical treatments in Europe causes about 200,000 deaths and burdens on health expenditure up to 80 billion euro a year (AIFA source). TRILLIO is a therapeutic adherence device really similar to an “alarm clock”, thus really familiar for elderly. The TRILLIO device is provided with an app that optimizes the connections among various players and organizations who share a common goal: make sure a patient follows his or her pharmaceutical treatment plan. When it's time to take a drug, TRILLIO alerts the user with a sound and a visual alarm, while showing all the relevant information on its 2.7' e-paper display. If the user doesn't press the button on the device to turn off the alarm within ten minutes, TRILLIO automatically sends a notification to any family member connected to the system. TRILLIO has been already tested in Italy and received serval endorsement by organisations in Italy and abroad. We are a targeting and overall population composed by 150.000.000 European that are suffering from Chronic diseases, 50% of them have difficulties in following a therapy: we are addressing 0,2% of this market and we are aiming at selling 112.000 devices by 2023, that will generate 17M€ turnover. The Feasibility study will have the purpose to support us in completing the market analysis, in launching a small pilot (i.e. 500/1.000 users), in identifying suitable partners in Europe for wide demo site (i.e. hospitals) and in identifying the right partners for distributing TRILLIO in Europe. TRILLIO is brought on the market by LA COMANDA, an Italian startup established under the Italian act for innovative startup, whose founders are Carlo Brianza and Andrea Gaggi, former executives of Nokia mobile team. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRILLIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TRILLIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

PRIVATETRACK (2019)

PRIVATETRACK: Privacy-friendly, low-power intelligent room occupancy detection and people counting.

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More